A cewar Steve Cowan, manajan tallan duniya na Sashen Kimiyya da Fasaha na Sandvik Material Technology, daga mahangar duniya, kasuwar na'urorin likitanci na fuskantar kalubale na raguwar da kuma tsawaita zagayowar haɓaka sabbin samfura, a halin yanzu, asibitoci sun fara rage farashi, kuma dole ne a tantance sabbin kayayyaki masu tsada a fannin tattalin arziki ko kuma a asibiti kafin a shiga.
"Ana ƙara tsaurara matakan kulawa kuma zagayowar tabbatar da samfura tana tsawaita. FDA a halin yanzu tana yin gyare-gyare kan wasu shirye-shiryen bayar da takardar shaida, waɗanda galibinsu sun haɗa da takaddun shaidar dashen ƙashi." in ji Steve Cowan.
Duk da haka, ba wai kawai game da ƙalubale ba ne. A cikin shekaru 20 masu zuwa, yawan jama'a sama da shekaru 65 a Amurka zai ƙaru da kashi 3% na shekara-shekara, kuma matsakaicin saurin duniya shine kashi 2%. A halin yanzu,haɗin gwiwaAdadin ci gaban sake ginawa a Amurka ya fi kashi 2%. "Kasuwa ta yi nazari kan cewa masana'antar za ta fita daga tushe a hankali a cikin sauyin yanayi kuma rahoton binciken sayen asibitoci a kwata na farko na wannan shekarar zai iya tabbatar da hakan. Sashen sayen asibitoci ya yi imanin cewa sayen zai sami ci gaba da kashi 1.2% a shekara mai zuwa inda shekarar da ta gabata ta shaida raguwar kashi 0.5% kawai." in ji Steve Cowan.
Kasuwannin China, Indiya, Brazil da sauran kasuwannin da ke tasowa suna da kyakkyawan fata a kasuwa, wanda ya fi dogara ne akan faɗaɗa tsarin inshora, ci gaban matsakaicin matsayi da kuma ƙaruwar kuɗin shiga na mazauna.
A cewar gabatarwar Yao Zhixiu, yanayin kasuwa na yanzudashen ƙashi na kashin bayaNa'urori da shirye-shirye iri ɗaya ne: manyan kasuwannin da asibitoci na farko suna ƙarƙashin kamfanonin ƙasashen waje, yayin da kamfanonin gida ke mai da hankali ne kawai kan asibitoci na sakandare da kasuwa mai ƙarancin riba. Duk da haka, kamfanonin ƙasashen waje da na cikin gida suna faɗaɗawa kuma suna fafatawa da biranen layi na biyu da na uku. Bugu da ƙari, duk da cewa masana'antar na'urorin dasawa a China yanzu tana da yawan ci gaban shekara-shekara na kashi 20% ko fiye, kasuwar tana ƙasa da tushe. A bara akwai ayyukan maye gurbin haɗin gwiwa miliyan 0.2 ~ 0.25, amma ƙaramin kaso ne kawai na yawan jama'ar China. Duk da haka, buƙatun China na na'urorin kiwon lafiya masu inganci suna ƙaruwa. A shekarar 2010, kasuwar dasawa na orthopedics a China ta wuce Yuan biliyan 10.
"A Indiya, kayayyakin dashen farce galibi suna cikin rukuni uku daban-daban: rukuni na farko shine samfurin inganci da kamfanonin ƙasashen duniya ke samarwa; rukuni na biyu shine kasuwancin gida na Indiya wanda ke mai da hankali kan kayayyakin matsakaicin matsayi na Indiya; nau'i na uku shine kasuwancin gida wanda ke mai da hankali kan kayayyakin matsakaicin matsayi na ƙasa da matsakaici. Wannan rukuni ne na biyu na kayayyakin matsakaicin matsayi wanda ya kawo canje-canje ga kasuwar na'urorin dashen farce ta Indiya, wanda ke haɓaka ci gaban masana'antar." Manis Singh, manajan aikace-aikacen Sandvik Medical Technology ya yi imanin cewa, irin wannan yanayi zai faru a China kuma masana'antun na'urorin likitanci za su iya koyon ƙwarewa daga kasuwar Indiya.
Lokacin Saƙo: Yuni-02-2022
